OEM Elevated Tbili Manufacturers & Service

Premium Clinical-Grade Botanical Extracts & Bile Acid Derivatives. Elevating Therapeutic Standards with ISO & FDA Certified Contract Manufacturing.

OEM Elevated Tbili Manufacturers: Resolving Hepatic Biomarker Management via Advanced Extract Synthesis

In modern clinical pharmacology, managing biomarkers related to liver distress is a core therapeutic target. Specifically, **Elevated Tbili (Total Bilirubin)** is a critical biomarker indicating hepatic parenchyma impairment, biliary tract obstruction, or accelerated hemolysis. To address this complex clinical indicator, international pharmaceutical enterprises and health supplement developers require robust active pharmaceutical ingredients (APIs) and standardized phytotherapeutic agents that support the biliary pathways. As a premier partner, Chengdu Chenlv Herb Co., Ltd. specializes in the scalable, high-purity contract manufacture of bile acid derivatives and botanical co-factors designed to stabilize and normalize bilirubin clearance.

Bile acids, including **Taurohyodeoxycholic acid (TUDCA)**, **Ursodeoxycholic acid (UDCA)**, and **Cholic acid**, have been clinically proven to stimulate choleretic activity, thereby directly addressing the etiology of hyperbilirubinemia. By improving bile flow and protecting hepatocytes from the cytotoxicity of hydrophobic bile acids, these ingredients effectively reduce the incidence of elevated Tbili levels. Our state-of-the-art OEM manufacturing plant leverages cutting-edge green chemistry and enzymatically driven synthesis to supply global enterprises with high-purity, premium-grade APIs tailored to hepatobiliary health.

Mechanisms of Action: How Bile Acid Derivatives Combat Elevated Bilirubin

Understanding how UDCA and TUDCA modulate total bilirubin levels requires an exploration of hepatic transport mechanics. The clearance of bilirubin relies on its conjugation in the hepatocyte by the enzyme UDP-glucuronosyltransferase 1A1 (UGT1A1), followed by its active transport across the canalicular membrane via the Multidrug Resistance-Associated Protein 2 (MRP2). Under pathologic conditions, these systems become saturated or down-regulated:

  • Hydrophilic Displace: Administering exogenous, highly hydrophilic bile acids like TUDCA replaces toxic hydrophobic bile acids within the systemic pool, reducing hepatocyte membrane degradation.
  • Transporter Up-regulation: Active ingredients trigger the transcription of MRP2 and BSEP (Bile Salt Export Pump) transporters via the activation of the Farnesoid X Receptor (FXR) and the Pregnane X Receptor (PXR).
  • Anti-apoptotic Cascade: TUDCA blocks mitochondrial membrane perturbation, suppressing caspase activation and preserving hepatocyte structure, which prevents the leakage of unconjugated bilirubin into the bloodstream.

About Chengdu Chenlv Herb Co., Ltd.

Established in 2012 — High-Tech Botanical & Pharmaceutical Pioneer

Chengdu ChenLv Herb Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of premium botanical extracts and natural pharmaceutical ingredients. We are dedicated to providing high-purity, highly active, and exceptionally reliable raw materials to the pharmaceutical, health supplement, functional food, and cosmetic sectors worldwide. By combining traditional herbal efficacy with modern biotechnological isolation, we ensure our global partners remain ahead of strict regulatory environments.

8+
Years of Specialized Production
2711㎡
Modern Factory Area
10+
Global Product Lineups
17+
Cooperative Client Networks
1+
Global Regions Served
2012
Year Established
Chenlv Herb Factory

Our Advantages

Choose Chenlv Herb for products that deliver beyond expectations

Innovative icon
INNOVATIVE
Creative designs, cutting-edge separation technologies, and custom-tailored active profiles that elevate your brand's market authority.
High Efficiency icon
High Efficiency
Eco-friendly processing, closed-loop solvent recovery, and rapid extraction matrices aligned with modern green-manufacturing mandates.
Sustainable icon
SUSTAINABLE
Fully traceable supply chains for natural herbs and botanical resources, ensuring reliable, long-term procurement viability.
Service icon
SERVICE
Fast and flexible lead times, custom labeling, and complete regulatory paperwork compilation designed to accelerate product launch schedules.
Quality Assurance icon
quality assurance
A dedicated quality control team employing HPLC, GC, AAS, and LC-MS testing to enforce zero-defect standards for every batch shipped.
Enrich Experience icon
Enrich Experience
Over a decade of deep chemical and botanical extraction experience ensuring maximum purity, precise formulation, and unparalleled excellence.

Macro Industry Outlook: Global Strategic Sourcing for Hepatoprotective APIs

The global demand for liver support drugs, therapeutic functional foods, and detoxifying agents is expanding rapidly. Driven by aging demographics, shifting metabolic profiles, and the rising global incidence of Non-Alcoholic Fatty Liver Disease (NAFLD/MAFLD) and biliary cholestasis, procurement departments of leading brands are shifting towards standardized, bio-available solutions. High-purity inputs that address systemic challenges like hyperbilirubinemia (elevated Tbili) are no longer niche; they are foundational to international preventive healthcare.

For procurement managers navigating complex supply landscapes, ensuring consistency in active content is paramount. B2B buyers face strict compliance frameworks, including the European Union's REACH regulation, the European Pharmacopoeia (EP), USP standards, and the United States FDA regulations. Partnering with a manufacturer like Chengdu Chenlv Herb, which operates under verified GMP parameters and possesses multiple international certifications, mitigates operational supply risk and guarantees batch-to-batch chemical conformity.

Technological Roadmap: Synthesis and Isolation Controls

To ensure therapeutic efficacy, the manufacturing profile of bile acid derivatives must be meticulously regulated. Chenlv Herb utilizes a specialized, Multi-Phase Biocatalytic Synthesis roadmap:

  1. Selection of Primary Cholic Intermediates: Raw materials undergo strict purity screening using high-resolution liquid chromatography (HPLC) to verify chemical identity.
  2. Controlled Conjugation Reactions: Synthesizing Taurohyodeoxycholic Acid requires precise molecular conjugation under controlled pH and thermal profiles. This prevents the generation of unwanted chemical isomers.
  3. Solvent Removal and Membrane Filtration: Employing advanced nanofiltration techniques eliminates heavy metals and organic solvent residues, conforming to the strictest limits set by pharmacopoeias.
  4. Lyophilization and Particle Engineering: The active materials are spray-dried or lyophilized under aseptic conditions, achieving consistent density, compressibility, and optimal dissolution profiles for oral dosage forms.

Customization Process

Chenlv Herb provides comprehensive, one-stop contract manufacturing services.

Step 1 icon 01

Cooperation Intention

Detailed consulting to map out target compound specifications, purities, and therapeutic goals.

Step 2 icon 02

Quotation

Providing transparent commercial quotes, batch size brackets, and precise lead-time estimates.

Step 3 icon 03

Sign the Contract

Formalizing partnership agreements, non-disclosure parameters, and quality criteria schedules.

Step 4 icon 04

Demand Customization

Developing laboratory-scale pilot batches and generating comprehensive certificates of analysis (COA) for approval.

Step 5 icon 05

Volume Production

Scheduling production within our GMP facility utilizing optimized reactor pipelines for scale efficiency.

Step 6 icon 06

Inspection

Executing rigid quality assays using chromatographical methods to verify compliance before batch release.

Step 7 icon 07

Shipment

Distributing securely packed materials worldwide under temperature-controlled shipping protocols.

Global Certificate & Compliance Display

Our facility and production lines are verified by leading international standardizations

ISO Certification
Halal Certification
Kosher Certification
FDA Registration
ISO22000 Certification
HACCP Certificate

Assuring Information Gain: Quantitative Control Strategies for Hepatobiliary Ingredients

In providing meaningful scientific data for pharmaceutical and health supplement formulation teams, our R&D center highlights the necessity of strict compound characterization. Bile acid chemistry presents challenges due to the existence of epimers—compounds with identical molecular formulas but different spatial configurations at specific carbon positions (such as the 7-alpha vs. 7-beta hydroxyl group of Chenodeoxycholic and Ursodeoxycholic acid). Misidentification can result in reduced therapeutic efficacy or unwanted systemic issues.

To maintain our position as a leading global manufacturer, Chengdu Chenlv Herb implements an analytical validation protocol. We employ Nuclear Magnetic Resonance (NMR) spectroscopy and High-Performance Liquid Chromatography coupled with Mass Spectrometry (HPLC-MS/MS) on every produced batch of bile acid intermediates. This ensures the complete absence of secondary bile acids like lithocholic acid (LCA), a hepatotoxic compound that must be restricted to less than 0.1% in human applications. Our commitment to analytical precision underpins the quality of every product we supply.

Environmental Sustainability and Modern Production Protocols

Sustainable sourcing in industrial biochemical extraction is a critical operational standard. At Chenlv Herb, we believe in minimizing environmental impact through the implementation of advanced membrane filtration technologies. Traditional botanical extraction processes often rely on heavy organic solvent consumption. To address this, our facility employs multi-stage cross-flow ultrafiltration and reverse osmosis loops. This system reduces water consumption by up to 40% and enables solvent recovery rates exceeding 95%. Through these measures, we deliver highly active ingredients while supporting global efforts toward carbon reduction and industrial sustainability.

Hepatobiliary Ingredients & OEM Service FAQ

Expert technical answers regarding our manufacturing standards, customization, and active formulations.

Q: How do bile acid derivatives like TUDCA help regulate elevated Tbili (Total Bilirubin) levels?
A: Bile acids stimulate bile secretion, which improves flow through the biliary tract. Exogenous administration of hydrophilic TUDCA displaces toxic hydrophobic bile acids, increases the expressions of canalicular membrane transporters like MRP2 and BSEP, and enhances the clearance of conjugated bilirubin from hepatocytes into the bile duct.
Q: What analytical validation methods do you utilize for batch releases?
A: Every batch undergoes rigorous quality control using HPLC, GC, LC-MS/MS, and Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for heavy metal profiling. Detailed Certificates of Analysis (COA) specifying exact active purity, moisture content, and particle size distribution are provided with each shipment.
Q: Can Chenlv Herb customize botanical extract purities and formulations?
A: Yes, our OEM service offers extensive customization. We can adjust the concentration of key active markers (e.g., Licochalcone A, Apigenin, Synephrine HCL, Cholic Acid) to match your specific formulation requirements. We also offer custom blending, granulation, and specialized packaging.
Q: Which international certifications does your manufacturing facility hold?
A: Chengdu Chenlv Herb operates a state-of-the-art facility certified by ISO9001, ISO22000, HACCP, HALAL, and KOSHER, and is registered with the United States FDA, satisfying strict global food safety and pharmaceutical compliance criteria.
Q: What is the typical lead time for custom batch production?
A: Standard lead times range from 4 to 6 weeks, which covers sample formulation, pilot testing, scale production, rigid quality assay runs, and final release clearance.
Q: How does Chenlv Herb guarantee the sustainability and traceability of its raw materials?
A: We enforce a strict supplier verification process, maintaining long-term agricultural partnerships for our botanical inputs. Every batch of raw materials is fully traceable back to its geographical cultivation origin, ensuring supply chain integrity.

Partner with an Established Industry Pioneer

Need high-purity bile acids or specialized botanical extracts? Contact our technical team today for quotes, samples, or custom formulation inquiries. We reply within 24 hours.

Submit RFQ / Contact Us

Latest Industry & Company Insights

Stay updated with research findings, market trends, and upcoming global exhibitions.

Citrus aurantium raw material price fluctuations
May 28, 2025 | Market Trends

The price of Citrus aurantium raw material rises, what is the market prospect of extract?

Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season comes to an end, supply-demand dynamics and cost considerations are driving fluctuations.

Read More →
CPHI China 2025 Event Invitation
May 28, 2025 | Corporate Events

Chengdu Chenlv Herb invites colleagues to explore new opportunities at 2025 CPHI China

As a leading platform for China's pharmaceutical industry on the global stage, CPHI China 2025 will join hands with the 18th China Pharmaceutical Machinery Exhibition to showcase next-generation extraction innovations.

Read More →
92nd API Conference Invite
May 28, 2025 | Exhibition

Chengdu ChenLv Herb invites you to attend the 92nd API conference

Join us at the upcoming API conference to discover new directions in biotechnology, discuss high-purity API production methodologies, and forge strategic partnerships.

Read More →